NASDAQ:AVTX | PE Ratio | Avalo Therapeutics, Inc.

Historical market capitalization divided by trailing-four-quarter filed net income.

Available history
2017-09-30 to 2025-03-31
Data captured

Historical PE Ratio

DatePE Ratio
2025-03-311.19
2018-06-3073,598.56
2018-03-3139,012.47
2017-12-3124,276.4
2017-09-304,787.47